Tag: mAbs
FACE TO FACE: Dr Prabuddha Kundu, Managing Director, Premas Biotech
Dr Prabuddha Kundu, Co-founder & Managing Director, Premas Biotech recently on the sidelines of Global Bio India 2024 in New Delhi shared his insights on his company focus on global collaborations, industry's key growth drivers, India's US$ 300 billion bioeconomy target by 2030 and much more.
Avantor completes acquisition of Masterflex®
The acquisition strengthens Avantor's offering across all bioproduction platforms including monoclonal antibodies (mAbs), cell and gene therapy